Literature DB >> 18402997

An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants.

Hephzibah Rani S Tagaram1, Alan M Watson, Francois A Lemonnier, Kevin Staveley-O'Carroll, Satvir S Tevethia, Todd D Schell.   

Abstract

The CD8+ T cell responses directed toward the VP1 antigens of human polyomaviruses JC and BK recently were shown to be cross-reactive. Two HLA-A0201-restricted determinants from each virus have been defined and include JCp100-108 (ILMWEAVTL) and BKp108-116 (LLMWEAVTV) as well as JCp36-44 (SITEVECFL) and BKp44-52 (AITEVECFL). We asked whether VP1 from the related SV40 contains similar HLA-A0201-restricted determinants. In this study, we demonstrate that CD8+ T cells specific for SV40 VP1 p110-118 (ILMWEAVTV), but not p46-54 (SFTEVECFL), can be induced in HLA-A0201-transgenic mice and that these CD8+ T cells cross-react with the corresponding determinants from JC and BK virus. The SV40 p110 determinant was found to be processed and presented in SV40-infected cells. These results indicate that the JCp36/BKp44 determinants are distinctive for the human polyomaviruses while the JCp100/BKp108/SVp110 determinants are shared by all three viruses, providing a target for CD8+ T cell cross-reactivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18402997      PMCID: PMC2464359          DOI: 10.1016/j.virol.2008.02.033

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  46 in total

1.  T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens.

Authors:  Michael A Brehm; Amelia K Pinto; Keith A Daniels; Jonathan P Schneck; Raymond M Welsh; Liisa K Selin
Journal:  Nat Immunol       Date:  2002-06-03       Impact factor: 25.606

2.  Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.

Authors:  Igor J Koralnik; Renaud A Du Pasquier; Marcelo J Kuroda; Jörn E Schmitz; Xin Dang; Yue Zheng; Michelle Lifton; Norman L Letvin
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

3.  Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.

Authors:  Raphael P Viscidi; Dana E M Rollison; Emma Viscidi; Barbara Clayman; Elizabeth Rubalcaba; Richard Daniel; Eugene O Major; Keerti V Shah
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

4.  Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy.

Authors:  B L Padgett; D L Walker
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

Review 5.  Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome.

Authors:  J S Butel; S S Tevethia; J L Melnick
Journal:  Adv Cancer Res       Date:  1972       Impact factor: 6.242

6.  Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.

Authors:  B L Padgett; D L Walker; G M ZuRhein; R J Eckroade; B H Dessel
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

7.  SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients.

Authors:  Robert K Bright; Eric T Kimchi; Michael H Shearer; Ronald C Kennedy; Harvey I Pass
Journal:  Cancer Immunol Immunother       Date:  2001-12-13       Impact factor: 6.968

Review 8.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.

Authors:  Renaud A Du Pasquier; Marcelo J Kuroda; Yue Zheng; Jims Jean-Jacques; Norman L Letvin; Igor J Koralnik
Journal:  Brain       Date:  2004-06-23       Impact factor: 13.501

10.  Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.

Authors:  Renaud A Du Pasquier; Marcelo J Kuroda; Joern E Schmitz; Yue Zheng; Kristi Martin; Fred W Peyerl; Michelle Lifton; Darci Gorgone; Patrick Autissier; Norman L Letvin; Igor J Koralnik
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more
  6 in total

1.  Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.

Authors:  Sharrón L Manuel; Todd D Schell; Edward Acheampong; Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  J Leukoc Biol       Date:  2009-08-05       Impact factor: 4.962

Review 2.  BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.

Authors:  George R Ambalathingal; Ross S Francis; Mark J Smyth; Corey Smith; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

3.  HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen.

Authors:  Bala Ramaswami; Iulia Popescu; Camila Macedo; Diana Metes; Marta Bueno; Adriana Zeevi; Ron Shapiro; Raphael Viscidi; Parmjeet S Randhawa
Journal:  Hum Immunol       Date:  2009-05-14       Impact factor: 2.850

4.  CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors.

Authors:  Angela M Tatum; Lawrence M Mylin; Susan J Bender; Matthew A Fischer; Beth A Vigliotti; M Judith Tevethia; Satvir S Tevethia; Todd D Schell
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

5.  Phenotypic and functional characterization of circulating polyomavirus BK VP1-specific CD8+ T cells in healthy adults.

Authors:  Michiel C van Aalderen; Ester B M Remmerswaal; Kirstin M Heutinck; Anja ten Brinke; Hanspeter Pircher; René A W van Lier; Ineke J M ten Berge
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

6.  Schweinfurthin induces ICD without ER stress and caspase activation.

Authors:  Ruoheng Zhang; J D Neighbors; T D Schell; R J Hohl
Journal:  Oncoimmunology       Date:  2022-08-03       Impact factor: 7.723

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.